Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

M. N. Bekker; L. Henneman; M. V.E. Macville; E. A. Sistermans; R. J.H. Galjaard

doi:10.1002/uog.22030

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

M. N. Bekker^*, L. Henneman, M. V.E. Macville, E. A. Sistermans, R. J.H. Galjaard

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	695-696
Number of pages	2
Journal	Ultrasound in Obstetrics and Gynecology
Volume	55
Issue number	5
DOIs	https://doi.org/10.1002/uog.22030
Publication status	Published - 1 May 2020

Access to Document

10.1002/uog.22030

Cite this

@article{00da42725df143e3ad5ce40cbd284984,

title = "Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data",

author = "Bekker, {M. N.} and L. Henneman and Macville, {M. V.E.} and Sistermans, {E. A.} and Galjaard, {R. J.H.}",

note = "Funding Information: All authors are affiliated with the Dutch NIPT Consortium that initiated the TRIDENT studies in The Netherlands. The TRIDENT studies are supported by a grant from The Netherlands Organization for Health Research and Development (ZonMw, No. 543002001).",

year = "2020",

month = may,

day = "1",

doi = "10.1002/uog.22030",

language = "English",

volume = "55",

pages = "695--696",

journal = "Ultrasound in Obstetrics and Gynecology",

issn = "0960-7692",

publisher = "John Wiley & Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

AU - Bekker, M. N.

AU - Henneman, L.

AU - Macville, M. V.E.

AU - Sistermans, E. A.

AU - Galjaard, R. J.H.

N1 - Funding Information: All authors are affiliated with the Dutch NIPT Consortium that initiated the TRIDENT studies in The Netherlands. The TRIDENT studies are supported by a grant from The Netherlands Organization for Health Research and Development (ZonMw, No. 543002001).

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85084888028&partnerID=8YFLogxK

U2 - 10.1002/uog.22030

DO - 10.1002/uog.22030

M3 - Letter

C2 - 32356934

AN - SCOPUS:85084888028

SN - 0960-7692

VL - 55

SP - 695

EP - 696

JO - Ultrasound in Obstetrics and Gynecology

JF - Ultrasound in Obstetrics and Gynecology

IS - 5

ER -

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

Access to Document

Other files and links

Cite this